Cargando…
Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676217/ https://www.ncbi.nlm.nih.gov/pubmed/36403422 http://dx.doi.org/10.1016/j.ebiom.2022.104368 |
_version_ | 1784833542886260736 |
---|---|
author | Ho, Bo Man Du, Lin Chu, Wai Kit |
author_facet | Ho, Bo Man Du, Lin Chu, Wai Kit |
author_sort | Ho, Bo Man |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9676217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96762172022-11-22 Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases Ho, Bo Man Du, Lin Chu, Wai Kit eBioMedicine Comment Elsevier 2022-11-17 /pmc/articles/PMC9676217/ /pubmed/36403422 http://dx.doi.org/10.1016/j.ebiom.2022.104368 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Comment Ho, Bo Man Du, Lin Chu, Wai Kit Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases |
title | Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases |
title_full | Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases |
title_fullStr | Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases |
title_full_unstemmed | Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases |
title_short | Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases |
title_sort | novel epigenetic therapy for th17 cell mediated autoimmune inflammatory diseases |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676217/ https://www.ncbi.nlm.nih.gov/pubmed/36403422 http://dx.doi.org/10.1016/j.ebiom.2022.104368 |
work_keys_str_mv | AT hoboman novelepigenetictherapyforth17cellmediatedautoimmuneinflammatorydiseases AT dulin novelepigenetictherapyforth17cellmediatedautoimmuneinflammatorydiseases AT chuwaikit novelepigenetictherapyforth17cellmediatedautoimmuneinflammatorydiseases |